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Background: Despite a symptom-based management recommended by
current guidelines in patients with primary mitral regurgitation (MR), the
assessment of maximal exercise capacity (MEC) is rarely performed. MEC is
relatively unexplored in these patients and its exercise determinants remain
unknown.
Method and results: We prospectively studied 63 asymptomatic patients
(60±13 years, 52% of male) with at least moderate MR and with preserved left
ventricular (LV) systolic function in whom comprehensive resting and exer-
cise echocardiography and cardiopulmonary exercise test were performed.
MEC was assessed using peak exercise VO2 and widely varied over patients
(mean: 23.6±7, median: 22.7, range: 10.2-42.4 ml/kg/min). According to the
median of peak VO2, patients with reduced MEC were significantly older
(p=0.0052) and were more frequently women (p=0.02). There was no other
significant difference between the 2 groups (reduced vs. preserved MEC)
regarding demographic and clinical data and medication. During exercise,
Peak VO2 was significantly correlated with exercise LV stroke volume
(r=–0.33, p=0.02) and there was a trend for significant correlation with
exercise RegV and effective regurgitant orifice area (r=–0.32, p=0.05 and
r=–0.3, p=0.07, respectively). In addition, the best correlations with peak VO2
were found with exercise SPAP (r=–0.52, p<0.0001) and exercise LA volume
(r=–0.59, p<0.0001). In multiple regression analysis (model r²=0.67), after
adjustment for exercise LV stroke volume and resting E/Ea, age (β=–0.17±
0.07, p=0.02), sex (β=–3.1±0.8, p=0.0006), exercise LA volume (β=–0.12±
0.03, p=0.02) and exercise SPAP (β=–0.15±0.06, p=0.0003) were identified as
independent predictors of peak exercise VO2.
Conclusion: In asymptomatic patients with primary MR and preserved LV
systolic function, MEC may vary considerably. The main independent deter-
minants of MEC are related to MR consequences on LA and SPAP, in partic-
ular during exercise.
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Haemodialysis: effects of acute decrease in preload on echocardio-
graphic indices of systolic and diastolic function of the left ventricle in
chronically uremic patients
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Conventional echocardiographic (ECHO) parameters of left ventricular
(LV) systolic and diastolic function have been shown to be load-dependent;
however, the impact of preload reduction on tissue Doppler (TD) parameters
of LV function is incompletely understood.
Objective: The aim of this study was to evaluate the effect of a single
hemodialysis (HD) session on left ventricular systolic and diastolic function
using conventional pulsed-Doppler echocardiography and pulsed tissue Dop-
pler imaging (TDI) in hemodialysis patients.
Methods: Eighty-one chronically uremic patients (40 males; aged
52,43±16,35 years) on maintenance hemodialysis underwent conventional 2D
and Doppler Echo together with measurement of longitudinal mitral annular
motion velocities. Echocardiographic parameters were obtained 30 minutes
before and 30 minutes after HD. Paired data were compared. Fluid volume
removed by HD was 1640 ±730 cm3.
Results: Hemodialysis led to reduction in LV end-diastolic volume
(p<0,001), end-systolic volume (p<0,001), left atrium area (p<0,001), peak
early (E wave) transmitral flow velocity (p <0,001), the ratio of early to late
Doppler velocities of diastolic mitral inflow (p <0,001) and aortic time
velocity integral (p<0.001). No significant change in peak S velocity of pul-
monary vein flow after HD. Early and late diastolic (Ea) TDI velocities and
the ratio of early to late TDI diastolic velocities (Ea/Aa) on the lateral side of
the mitral annulus decreased significantly after HD (p=0,013; p=0,007 and
p=0,008; respectively).
Velocity of flow progression (Vp) during diastole was not affected by pre-
load reduction. Pulmonary artery systolic pressure and the diameter of the
inferior vena cava decreased significantly (p <0,001and p <0,001; respec-
tively) after HD.
Conclusions: Most of Doppler-derived indices of diastolic function are
preload-dependant. Velocity of flow progression was not or minimally
affected by preload reduction in hemodialysis patients.
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Comparison of gated SPECT ejection fraction measured immediately
and more than 40 minutes after stress resting using a fast camera
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The aim of this study is to compare the gated SPECT ejection fraction (EF)
measured a few minutes (mn) after stress and more than 40 mn after stress by
using Myoview as tracer and a gamma camera with fast acquisition (GE dis-
covery). It is generally accepted that patients without severe ischemia have a
post stress ejection fraction equal to the post rest one. It is also accepted that
a difference of more than 5% in absolute value between 2 EF is considered as
significantly different.
Methods and results: In our study 111 patients, mean age 59,7 years,
without known coronary artery disease (CAD), had first a 4 mn fast camera
acquisition. The mean delay between myoview injection and beginning of
SPECT imaging was 3,83 mn+/- 2,98 with a mean cardiac rate of 86,86±26
bpm. The secon acquisition was done after 42,89 mn+/- 19 mn and the mean
cardiac rate was 74,34+/- 22 bpm. Mean difference in the delay is 39 mn (Max
64, Min 22). The average value of the immediate EF (computed from the first
scan) was 71,55 +/-17,'4% and the average value of the delayed EF (computed
from the second scan) was 64,68+/- 16,8%.The resulting mean difference is
6,86+/-14 which is significant. Mean difference between the end diatolic
volume is –5,16 and –7,26 for the end systolic volume. Myocardial perfusion
was normal in all the patients.
Conclusion: The EF value measured on a scan done just after the stress
test is significantly higher than the one mesured after a delay of about
40 mn This is an interesting result as a lower than expected ejection frac-
tion value after stress compared to the rest one may be an argument for a
severe CAD.
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change in diagnosis and surgery planned
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Introduction: The value of routine use of transesophageal echocardiog-
raphy (TOE) in cardiac surgery has been rarely studied in a consecutive series
of patients. The aim of this study was to evaluate the contribution of periop-
eratively TOE in cardiac surgery.
Material and methods: This is a prospective study of thirty two consecu-
tive patients undergoing cardiac surgery, in a programmed manner. The data
of TOE were compared with preoperative diagnosis retained. In some cases,
changing diagnostic led to a modification of the planned intervention. The
contributions of TOE were to elucidate of the mechanism of valvular disease,
assess its severity, to diagnose morphological, guiding surgery and checking
results at the end of the intervention
Results: The main types of interventions were: valve replacement or
valvuloplasty (51%), CABG (37%), aortic surgery (12%). The diagnosis
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made preoperatively was modified in 10% of cases (n=21). In 54% of
cases, TOE confirmed the diagnosis previously established by transthoracic
echocardiography, in 10% of cases the diagnosis made preoperatively was
changed, and in 28% of TOE has provided diagnostic and therapeutic solu-
tion. The results found for each type of surgical pathology are reported in
Table
Discussion: TOE performed routinely during cardiac surgery may lead to
changes in surgery, particularly in the aortic pathology and valvular diseases.
In about half of the indications for which review is requested, the supply of
TOE is decisive and modifies the treatment instituted.
Conclusion: Our study confirms the value of TOE in cardiac surgery, in
addition to the indications found in our series of patients, others such as aortic
dissection or pulmonary embolism major benefit from the addition of TOE.
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Background: Cardiovascular magnetic resonance (CMR) with endocardial
delineation of the right ventricle is the gold standard to measure right ventri-
cular ejection fraction (RVEF). Longitudinal shortening is historically known
to be the predominant part of its global systolic function and less attention has
been paid to the transversal contraction. The aim of this study was to evaluate
RV transverse motion in a large cohort of patients referred for CMR and
assess its relationship with RVEF.
Method: We retrospectively analyzed the CMR scans of 300 consecu-
tive patients referred for CMR between January and December 2010.
Reference RV ejection fraction was determined from short axis sequence
after delineating endocardial contours. Transverse parameters called RV
fractional diameter changes were calculated after measuring RV diastolic
and systolic diameters at basal and medial level in short axis view (respec-
tively FBDC and FMDC). We also measured the tricuspid annular plane
systolic excursion (TAPSE) in the four chambers view as a longitudinal
reference.
Results: Population was divided into 2 groups according the RVEF.
250 patients had a preserved RVEF (>40%) and 50 had a RV dysfunction
(RVEF≤40%). Both transverse and longitudinal motions were significantly
reduced in the group with RV dysfunction (p<.0001). After ROC analysis,
areas under the curve for FBDC, FMDC and TAPSE, were respectively 0,79,
0,82 and 0,72 with the highest sensitivity and specificity of 68% and 88% for
FMDC (threshold at 19.9%) to predict RVEF. Above all, FMDC had a 93%
negative predictive value of altered RVEF.
Conclusion: Right ventricular transversal systolic function markers,
especially at the medial level, appear to be accurate for assessment of RV
function by CMR. They are reliable to rule out an RV dysfunction in clinical
practice.
Keywords : Right ventricular ejection fraction, transversal systolic func-
tion, semi-quantitative assessment, cardiac magnetic resonance.
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The interrelation between diastolic function indexes and interleukin-6
level in patients with metabolic cardiomyopathy
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Myocardial injury in diabetes mellitus type 2 (DM-2) is associated not only
with insulin resistance, hyperinsulinemia and glucose toxicity, but also with
the action of anti-inflammatory cytokins, which accelerate the development of
atherosclerotic changes. One of the representatives of cytokins is interleukin-
6 (IL-6). Its activation is a marker of disease severity and the predictor of
development of late cardiovascular complications. However, the extent of IL-
6 involvement into the development of diastolic dysfunction (DD), typical for
metabolic cardiomyopathy (MC), is not well studied.
Therefore, the aim of our research was to evaluate the correlation between
the maximal velocity of early diastolic stream E – stream velocity caused by
atrial systoles A ratio and the level of IL-6 in patients with DM-2.
Methods: 38 patients (35-60 years old) with DM-2 without severe compli-
cations were examined. Duration of DM-2 was from 1 to 8 years. The level of
IL-6 was determined by immune-enzyme assay. The maximal velocity of early
diastolic stream E; stream velocity, caused by atrial systoles A; and an E/A ratio
were measured by heart sonography. Control group included 20 relatively
healthy individuals. Correlation analysis was applied to all studied indexes. Cor-
relation coefficient and degree of reliability of received data were counted.
Results: Mean level of E/A composed 0,93±0,04 (p<0,05) in the group of
patients with DM-2 and 1,4±0,075 (p<0,05) in the control group. The mean
level of IL-6 counted 10,7±0,27 (p<0,05) in group of patients with DM-2 and
8,83±0,22 in the control group (p<0,05). A significant reliable negative corre-
lation was revealed between E/A ratio and IL-6 level (Spearman’s rank corre-
lation coefficient R –0,32 (p<0,05)).
Conclusion: The received data prove that IL-6 contributes the development
of diastolic dysfunction in patients with MC and DM-2. IL-6 favours the devel-
opment of DD first, following systolic dysfunction in patients with DM-2.
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Introduction: Ivabradine is a selective heart-rate-lowering agent that acts
on the sinoatrial node without influence on myocardial contractility and car-
diac output. Physiological effects of ivabradine during dobutamine infusion
have never been studied.
Methods: The study included 11 healthy subjects (82% men, aged 29.1±
4.7 years). All underwent dobutamine transthoracic echocardiography before
and after ivabradine (3 hours after 5 mg of ivabradine). Baseline left ventric-
ular longitudinal global strain by speckle tracking and stroke volume at rest
and during low dose of dobutamine (when heart rate increased by more than
10 points from baseline) were compared to those obtained under ivabradine.
Results: Baseline heart rate (64±8 bpm) decreased in 7 subjects (68±7 bpm
vs. 60±6 bpm, P=0.009) but paradoxically increased in 3. Dobutamine rate
required to increase the heart rate by 10 points was similar with and without
ivabradine (11±2γ/kg/min vs. 12±3 γ/kg/min, P=0.4). Overall, global strain
increased under low dose dobutamine before (–20±2% vs. –23±2%, P=0.008)
and after ivabradine (–21±2% vs. –23±3%, P< 0.001). Interestingly, in the
7 subjects that responded to ivabradine, global strain (–23±2% vs. –25±1%,
P=0.006) and stroke volume (102±17 ml vs. 110±20 ml, P=0.05) more
increased under dobutamine with ivabradine.
Conclusion: In healthy subjects, heart rate reduction obtained by ivabra-
dine allows to increase myocardial contractility and stroke volume for a sim-
ilar rate of dobutamine. This propriety may be useful in decompensate heart
failure patients with rapid tachycardia induced by catecholamine infusion.
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